Kinetics of mast cell, basophil, and oral food challenge responses in omalizumab-treated adults with peanut allergy

Journal of Allergy and Clinical Immunology

Volumn 130, Issue 5, 2012, Pages

  Savage, Jessica H ^a   Courneya, Jean Paul ^a   Sterba, Patricia M ^a   Macglashan, Donald W ^a   Saini, Sarbjit S ^a   Wood, Robert A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

basophil; mast cell; Omalizumab; oral food challenge; peanut allergy

Indexed keywords

ALLERGEN; HISTAMINE; IMMUNOGLOBULIN E; OMALIZUMAB;

ADULT; ARTICLE; BASOPHIL; CELL FUNCTION; CELL KINETICS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL EFFECTIVENESS; CORRELATION COEFFICIENT; DOUBLE BLIND PROCEDURE; FEMALE; FLUOROMETRY; HISTAMINE RELEASE; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; MALE; MAST CELL; ORAL FOOD CHALLENGE; OUTCOME ASSESSMENT; PEANUT ALLERGY; PRIORITY JOURNAL; PROVOCATION TEST; SKIN TEST; TREATMENT RESPONSE;

EID: 84869134114     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2012.05.039     Document Type: Article

References (13)

1. L.A. Beck, G.V. Marcotte, J.D. MacGlashan, A. Togias, and S. Saini Omalizumab-induced reductions in mast cell FcεRI expression and function J Allergy Clin Immunol 114 2004 527 530 (Pubitemid 39194924)
2. J.A. Eckman, P.M. Sterba, D.A.V. Kelly, M.C. Liu, B.S. Bochner, and D.W. MacGlashan Effects of omalizumab on basophil and mast cell responses using an intranasal cat allergen challenge J Allergy Clin Immunol 125 2010 889 895
3. D.Y. Leung, H.A. Sampson, J.W. Yunginger, A.W. Burks Jr., L.C. Schneider, and C.H. Wortel Effect of anti-IgE therapy in patients with peanut allergy N Engl J Med 348 2003 986 993 (Pubitemid 36302243)
4. H.A. Sampson, D.Y. Leung, A.W. Burks, G. Lack, S.L. Bahna, and S.M. Jones A phase II, randomized, double blind, parallel group, placebo controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy J Allergy Clin Immunol 127 2011 1309 1310
5. B.M. Vonakis, K. Vasagar, J.S.P. Gibbons, L. Gober, P.M. Sterba, and H. Chang Basophil FcεRI histamine release parallels expression of Src-homology 2-containing inositol phosphatases in chronic idiopathic urticaria J Allergy Clin Immunol 119 2007 441 448 (Pubitemid 46204799)
6. S.S. Saini, J.J. Richardson, C. Wofsy, S. Lavens-Phillips, B.S. Bochner, and D.W. MacGlashan Expression and modulation of FcεRIα and FcεRIβ in human blood basophils J Allergy Clin Immunol 107 2001 832 841 (Pubitemid 32436917)
7. B. Niggemann, U. Wahn, and H.A. Sampson Proposals for standardization of oral food challenge tests in infants and children Pediatr Allergy Immunol 5 1994 11 13 (Pubitemid 24072045)
8. J. Bousquet, S. Wenzel, S. Holgate, W. Lumry, P. Freeman, and H. Fox Predicting response to omalizumab, an anti-IgE antibody, in patients with allergic asthma Chest 125 2004 1378 1386 (Pubitemid 38501353)
9. W.W. Busse, W.J. Morgan, P.J. Gergen, H.E. Mitchell, J.E. Gern, and A.H. Liu Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children N Engl J Med 364 2011 1005 1015
10. K.C. Nadeau, L.C. Schneider, L. Hoyte, I. Borras, and D.T. Umetsu Rapid oral desensitization in combination with omalizumab therapy in patients with cow's milk allergy J Allergy Clin Immunol 127 2011 1622 1624
11. H. Sussman, A. Davidson, and M. Walzer Absorption of undigested proteins in human beings Arch Intern Med 42 1928 409 414
12. D.W. MacGlashan Jr., J. Savage, R. Wood, and S. Saini Suppression of the basophil response to allergen during treatment with omalizumab is dependent on 2 competing factors J Allergy Clin Immunol 130 2012 1130 1135
13. H.A. Sampson, K.R. Broadbent, and J. Bernhisel-Broadbent Spontaneous release of histamine from basophils and histamine-releasing factor in patients with atopic dermatitis and food hypersensitivity N Engl J Med 321 1989 228 232 (Pubitemid 19187164)